Eupraxia Pharmaceuticals (EPRX) EBIT (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted EBIT of -$14.46 million for the quarter ended Jun 30, 2026, compared with -$8.74 million a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) EBIT (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Eupraxia Pharmaceuticals was -$50.18 million; for the year ended Dec 31, 2025, it was -$38.59 million.
- In prior years, Eupraxia Pharmaceuticals' EBIT was -$26.35 million in the year ended Dec 31, 2024, -$30.1 million in the year ended Dec 31, 2023 and -$19.97 million in the year ended Dec 31, 2022.
- Quarterly EBIT has run from a low of -$16.71 million in the quarter ended Dec 31, 2025 to a high of -$4.25 million in the quarter ended Mar 31, 2023 over five years.
- According to Business Quant data, EBIT for the three prior quarters was -$12.64 million (quarter ended Mar 31, 2026), -$16.71 million (quarter ended Dec 31, 2025) and -$6.37 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Eupraxia Pharmaceuticals | 308.46 Mn | -133.60 Mn | - | -14.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.46 Mn |
| Mar 31, 2026 | -12.64 Mn |
| Dec 31, 2025 | -16.71 Mn |
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | -8.74 Mn |
| Mar 31, 2025 | -6.76 Mn |
| Dec 31, 2024 | -6.32 Mn |
| Sep 30, 2024 | -5.99 Mn |
| Jun 30, 2024 | -6.35 Mn |
| Mar 31, 2024 | -6.47 Mn |
| Jun 30, 2023 | -9.81 Mn |
| Mar 31, 2023 | -4.25 Mn |
API Access
Eupraxia Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();